ZandCellZandCell
  • HOME
  • About
    • About
    • News Releases
  • Programs
  • Science
  • Apply
  • Contact
  • Login

    Lost your password?

  • 0
    Cart
  1. Home
  2. B. C. girl with leukemia seeks Christmas stem cell donor – DigitalJournal.com
  3. NEWS

NEWS

New gene therapy treatment routes for motor neurone disease uncovered in new study – EurekAlert (press release)

New gene therapy treatment routes for motor neurone disease uncovered in new studyEurekAlert (press release)Scientists investigating the genetic causes and altered functioning of nerve cells in motor neurone disease (MND) have discovered a new mechanis… Continue reading

2017-07-14 Michael Zand NEWS

Milk without cows, eggs without chickens? Synthetic biology could … – Genetic Literacy Project

Genetic Literacy ProjectMilk without cows, eggs without chickens? Synthetic biology could …Genetic Literacy ProjectBio-hacking applies technology in innovative ways to modify biological systems like cells, plants, animals – and Homo sapiens. Bio-hack… Continue reading

2017-07-14 Michael Zand NEWS

Milk without cows, eggs without chickens? Synthetic biology leads to more sustainable food – Genetic Literacy Project

Continue reading

2017-07-14 Michael Zand NEWS

T-cell cancer therapy holds promise, longer-term results await – Business Insider


Genetic Literacy Project

Milk without cows, eggs without chickens? Synthetic biology leads to more sustainable food
Genetic Literacy Project
Bio-hacking applies technology in innovative ways to modify biological systems like cells, plants, animals – and Homo sapiens. Bio-hacker Hannes Sjoblad believes bio-hacking is all about the democratization of access to powerful technologies for the …

and more »

Continue reading

2017-07-14 Michael Zand NEWS

Editas Medicine, Inc. (NASDAQ:EDIT) Stock Traded 6.6% Above Its 50 Day Average – Highlight Press

Editas Medicine, Inc. (NASDAQ:EDIT) Stock Traded 6.6% Above Its 50 Day AverageHighlight PressCRISPR uses a protein-ribonucleic acid (RNA) complex composed of an enzyme, including either Cas9 (CRISPR associated protein 9) or Cpf1 (CRISPR from Prevotella… Continue reading

2017-07-14 Michael Zand NEWS

Editas Medicine, Inc. (NASDAQ:EDIT) Stock Traded 6.6% Above Its 50 Day Average – Highlight Press

Editas Medicine, Inc. (NASDAQ:EDIT) Stock Traded 6.6% Above Its 50 Day AverageHighlight PressCRISPR uses a protein-ribonucleic acid (RNA) complex composed of an enzyme, including either Cas9 (CRISPR associated protein 9) or Cpf1 (CRISPR from Prevotella… Continue reading

2017-07-14 Michael Zand NEWS

Editas Medicine, Inc. (NASDAQ:EDIT) Closed 6.6% Above Its 50 … – Finance Daily

Editas Medicine, Inc. (NASDAQ:EDIT) Closed 6.6% Above Its 50 …Finance DailyShares are trading at $17.71 just above the 50 day moving average of $16.62 and just a bit lower than the 200 day moving average of $19.13. The 50 day …and more &r… Continue reading

2017-07-14 Michael Zand NEWS

SunTrust Robinson Humphrey Begins Coverage on Editas Medicine, Inc. (EDIT) Giving It An Initial Rating Of “Hold” – Highlight Press


Pulse Headlines

T–cell cancer therapy holds promise, longer-term results await
Business Insider
The new drug class, known as chimeric antigen receptor T–cell or CAR-T, involves a complicated process of extracting immune system T–cells from an individual patient, altering the cell DNA to sharpen their ability to spot and kill cancer cells, and …
Novel leukemia treatment could be 1st US gene therapySumter Item
FDA advisory committee recommends approval of T–cell ‘living drug’ to treat leukemiaPulse Headlines

all 17 news articles »

Continue reading

2017-07-14 Michael Zand NEWS
  • 1
  • …
  • 1,495
  • 1,496
  • 1,497
  • 1,498
  • 1,499
  • …
  • 3,595
Recent Posts
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Шведская компания ZandCell поставит 160 млн доз вакцины от COVID-19 в несколько стран мира 2021-07-22
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
About Us

ZandCell is a biotechnology company pioneering the advancements and therapeutic applications of Stem Cell Therapy. Our Technology is called “Regenerate”.

SiteLock
Contact Info
+1-702-425-9049
+46-736-779970
info@zandcell.com
Find us on map


Latest News
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Official PayPal Seal


© 2024 ZandCell. All Rights Reserved.
  • About
  • Programs
  • Science
  • Privacy Policy
  • Contact
  • RSS
  • Send us email
  • Follow us on Twitter
  • Follow us on Facebook
  • Follow Us on Linkedin
  • Call us via Skype
  • Follow Us on Instagram
  • Subscribe our YouTube Channel
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.

SunTrust Robinson Humphrey Begins Coverage on Editas Medicine, Inc. (EDIT) Giving It An Initial Rating Of “Hold”
Highlight Press
CRISPR uses a protein-ribonucleic acid (RNA) complex composed of an enzyme, including either Cas9 (CRISPR associated protein 9) or Cpf1 (CRISPR from Prevotella and Francisella 1), bound to a guide RNA molecule designed to recognize a particular …

and more »